Hemi Dimant

2010-2013 Neurology Massachusetts General Hospital, Boston, MA 
"Hemi Dimant"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Hudry E, Martin C, Gandhi S, et al. (2016) Exosome-associated AAV vector as a robust and convenient neuroscience tool. Gene Therapy
Dimant H, Zhu L, Kibuuka LN, et al. (2014) Direct visualization of CHIP-mediated degradation of alpha-synuclein in vivo: implications for PD therapeutics. Plos One. 9: e92098
McFarland NR, Dimant H, Kibuuka L, et al. (2014) Chronic treatment with novel small molecule Hsp90 inhibitors rescues striatal dopamine levels but not α-synuclein-induced neuronal cell loss. Plos One. 9: e86048
Dimant H, Kalia SK, Kalia LV, et al. (2013) Direct detection of alpha synuclein oligomers in vivo. Acta Neuropathologica Communications. 1: 6
Dimant H, Ebrahimi-Fakhari D, McLean PJ. (2012) Molecular chaperones and co-chaperones in Parkinson disease. The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry. 18: 589-601
Dimant H, Solomon B. (2010) Filamentous phages reduce alpha-synuclein oligomerization in the membrane fraction of SH-SY5Y cells. Neuro-Degenerative Diseases. 7: 203-5
Dimant H, Sharon N, Solomon B. (2009) Modulation effect of filamentous phage on alpha-synuclein aggregation. Biochemical and Biophysical Research Communications. 383: 491-6
See more...